D

Tirzepatide Updates

By Diana Isaacs 10 Videos
8,054 views
August 29, 2023
7 Comments
Login to view comments. Click here to Login

Featured Video

02:17
Novartis Cardiology

Understanding Acquisition and Billing for a Non-Statin Lipid-Lowerin…

Feat. B. Buell

Featured Video

48:22
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…

Feat. B. Hirsch

Related Content

AUTOPLAY
47:11
Houston Methodist

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
34:49
Scripps Health

Medications for Weight Loss: The New Satiety Hormones

Feat. K. Fujioka
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
23:35
Practical Ways to Achieve Targets in Diabetes Care

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Feat. I. Hirsch
19:24
National Lipid Association

Do Triglycerides Cause Heart Disease?

Feat. I. Goldberg
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

20:15
Omnipod®

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Feat. F. Pasquel
03:16
Michigan Medicine - Podiatry

Diabetic Peripheral Neuropathy: A Review of Clinical Practice Guidel…

Feat. G. Rothenberg
18:46
Houston Methodist

MAFLD: What Is It?

Feat. D. Victor
40:48
Michigan Medicine

Incretin-based Therapies in the Management of Obesity and its Comorb…

Feat. A. Rothberg
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

08:35
Susan Brian

Labs to Check on Semaglutide or Tirzepatide

11:36
Columbia University Institute of Human Nutrition

Rainbow Lentil Soup: Columbia / IHN Breast Cancer Awareness Culinary…

Feat. O. Weinstein
33:23
Keck School of Medicine of USC

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Feat. M. Goran